Pyxis Oncology
Stephen Worsley is an accomplished business executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as the Chief Business Officer at Pyxis Oncology, Stephen has held prominent roles including Managing Director at Miramonte Capital Advisors and Chief Business Officer at Lytix Biopharma and Sutro Biopharma, Inc. Additionally, Stephen has contributed to strategic business development as Vice President at Redwood Biosciences/Catalent Pharma Solutions.
This person is not in any teams
This person is not in any offices
Pyxis Oncology
2 followers
Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.